Pfizer profit misses estimates, revenue declines as Lyrica sales tumble

Pfizer Inc on Tuesday reported lower-than-expected quarterly profit and a decline in revenue as sales of its off-patent pain treatment Lyrica more than halved, sending its shares down more than 3%.